The stock I rolled my profits from into AMBS made
Post# of 30028
LymPro is way bigger than that drug!
Joe Rubenfeld: "We're launching a diagnostic in 4 months. We're there!"
You all may think we're about MANF, and that's fine, we will be one day. But right now we are all about LymPro revenue that will soon be within the market's eyesight. Next week's data will only increase that reality.
The market loves and rewards revenue machines. That's what Lympro is.
Solantey and the flippers can only profit if naive longs play into their hands by selling. If everyone recognizes the game that is being played....Solantey and the flippers will have to behave.
We can do this.